Clinical trials of pharmacologic treatments in pregnant women--methodologic considerations.
Schottenfeld
R S
RS
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA.
D001971:Bromocriptine / Q000627:therapeutic use; D002047:Buprenorphine / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards*; D003891:Desipramine / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009538:Nicotine / Q000008:administration & dosage; D018722:Nicotinic Agonists / Q000008:administration & dosage; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D012107:Research Design; D019966:Substance-Related Disorders / Q000188:drug therapy*
D018491:Dopamine Agonists; D009292:Narcotic Antagonists; D018722:Nicotinic Agonists; D001971:Bromocriptine; D002047:Buprenorphine; D009538:Nicotine; D003891:Desipramine